On April 4, 2022, Jeffery Baxter notified ChromaDex Corporation (the Company") of his intention to resign from the board of directors of the Company (the Board") and as a member of the Audit Committee and Nominating and Corporate Governance Committee of the Board. The effective date of Mr. Baxter's resignation is April 4, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.08 USD | 0.00% | +10.39% | +115.38% |
06-07 | Sector Update: Health Care Stocks Higher Late Afternoon | MT |
06-07 | ChromaDex Says US FDA Grants NRC Orphan Drug, Rare Pediatric Disease Designations -- Shares Climb Pre-Bell | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+115.38% | 233M | |
+49.21% | 56.87B | |
+36.75% | 39.72B | |
-6.86% | 39.27B | |
-4.42% | 28.73B | |
+12.00% | 26.21B | |
-18.27% | 19.79B | |
+29.57% | 12.28B | |
+25.41% | 12.23B | |
-0.35% | 12.12B |
- Stock Market
- Equities
- CDXC Stock
- News ChromaDex Corporation
- Jeffery Baxter Notifies His Intention to Resign from Board of ChromaDex